Levadopa and pyridoxine.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000378:metabolism*; D004347:Drug Interactions; D006801:Humans; D006834:Hydrazines / Q000378:metabolism* / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008750:Methyldopa / Q000494:pharmacology; D051379:Mice; D010300:Parkinson Disease / Q000188:drug therapy; D011422:Propionates / Q000494:pharmacology; D011736:Pyridoxine / Q000494:pharmacology*
D006834:Hydrazines; D011422:Propionates; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D011736:Pyridoxine